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According to a 1998 World Health Organization Survey of 26 000 primary care patients on five continents, 22% reported per-
sistent pain over the past year. Part of the problem lies with some health-care providers who have failed to keep up with the ad-
vances in pain medicine and continue to follow the biomedical approach, which regards a specific pathway as the only source 
of pain. In this model, all pain is regarded as a warning signal of tissue injury, and if conservative treatment fails, some surgical 
technique will be able to correct the problem.
The modern paradigm of pain management has moved from this biomedical to the broader biopsychosocial approach, 
where pain mechanisms now integrate input from sensory, emotional and cognitive systems.
Introduction
The pain processing (nociception) sys-
tem was historically conceptualised 
as a “hard-wired” pain pathway which 
reproduces a pain sensation in direct 
proportion to the extent and severity of 
the painful (noxious) insult. However, 
this concept was challenged from the 
1940’s and the gate-control theory of 
pain mechanisms published by Mel-
zack and Wall in 1965, had a profound 
influence in the field of pain research 
and in the development of various forms 
of pain therapy.1 This theory integrates 
the views of neurophysiology and psy-
chology and states that spinal transmis-
sion of pain impulses is continuously 
modulated by the relative activity in 
the small (A-delta and C) fibres and the 
large (A-beta) fibres and by descending 
messages from the brain that originate 
in the cerebral cortex and brainstem. In 
subsequent years the theory has been 
criticised as an over-simplification and 
a series of “gates” at different levels of 
the spinal cord and in the higher centres 
have been postulated.
The modern discipline of pain manage-
ment was launched by the publication 
of the first edition of John F. Bonica’s 
Management of Pain in 1953,2 and he 
established the first interdisciplinary 
pain clinic in 1947 at the University of 
Washington in Seattle to treat the pain of 
war veterans.
Despite many advances over the 
past 50 years, poorly controlled pain 
remains a worldwide problem. Accord-
ing to a 1998 World Health Organization 
Survey of 26 000 primary care patients 
on five continents, 22% reported persis-
tent pain over the past year.3 Part of the 
problem lies with some health-care pro-
viders who have failed to keep up with 
the advances in pain medicine and con-
tinue to follow the biomedical approach, 
which regards a specific pathway as 
the only source of pain. In this model, 
all pain is regarded as a warning signal 
of tissue injury, and if conservative treat-
ment fails, some surgical technique will 
be able to correct the problem.4,5
The modern paradigm of pain 
management has moved from this bio-
medical to the broader biopsychosocial 
approach, where pain mechanisms now 
integrate input from sensory, emotional 
and cognitive systems.4,6,7
The current definition of pain as 
proposed by the IASP, reads: “Pain is 
an unpleasant sensory and emotional 
experience associated with actual or 
potential tissue damage, or described in 
terms of such damage”.8 This definition 
identifies the complex and multi-dimen-
sional experience of pain, where the 
patient’s physical, cognitive, emotional 
and behavioural characteristics mediate 
the pain experience.9
With acute pain of known cause, 
there may only be a minor contribution 
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Figure 1: Biopsychosocial model of pain4,6,7
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sions – in patients with a chronic pain 
disorder for many years, these dimen-
sions may play a major role in pain per-
ception.10
A multitude of brain regions (known 
as the “pain matrix”) are activated follow-
ing a pain stimulus. Rather than regis-
tering the pain signal to produce pain 
perception, the brain matrix constructs 
the pain experience by integrating multi-
ple inputs, including biological (sensory) 
factors, present and past psychological 
events and socio-cultural influences.
Acute pain 
Acute pain is a normal biological re-
sponse to injury or tissue trauma and 
a signal of ongoing or impending tis-
sue damage, e.g. post-operatively. It 
protects the organism from further in-
jury and promotes healing after injury. 
Acute pain is a symptom that must be 
treated or its cause eliminated.11,12 Un-
treated acute pain may cause unneces-
sary suffering and increase morbidity, it 
may also lengthen the recovery time af-
ter tissue injury.
There is increasing recognition that 
long-term changes may occur within 
the peripheral and central nervous sys-
tem following the noxious input of pain-
ful stimuli. Even brief intervals of un-
treated acute pain can induce long-
term neuronal remodelling and central 
sensitization (“plasticity”) and may lead 
to chronic pain in some patients. This 
“plasticity” of the nervous system then 
alters the body’s response to further 
sensory input, it becomes more sensi-
tive to pain impulses and even innoc-
uous stimuli may then trigger pain per-
ception.1,11,12,13 
Central sensitization is a complex pro-
cess involving many neurochemical and 
molecular processes, and is induced 
by the release of neuropeptides such 
as substance P and glutamate, which 
then activate the NMDA-receptor-com-
plex.2,13,14 The subsequent intra-cellular 
events may lead to long-term neuronal 
changes, characterized by a more sen-
sitive nervous system and hyperalgesia.
Acute post-operative pain may be fol-
lowed by persistent pain in 10-40% of in-
dividuals, in particular after procedures 
such as inguinal hernia repair, thoracot-
omy, and breast surgery.15 Central sen-
sitization after tissue and nerve injury 
is also believed to be a mechanism for 
this phenomenon. Current data there-
fore support a comprehensive and multi-
modal approach to post-operative pain 
management.16 Pain intensity should be 
assessed routinely, just as one monitors 
other vital signs, to ensure that acute 
pain is managed appropriately.
Primary types of pain11,12
Nociceptive pain (e.g. trauma, sur-
gery)
Nociceptive pain occurs when intact pe-
ripheral nerve endings (nociceptors) are 
stimulated by noxious stimuli that may 
be mechanical, thermal or chemical. 
Tissue damage generates release of 
peptides and other components of the 
inflammatory soup with eventual periph-
eral sensitization. Peripheral sensitiza-
tion is one way in which the nociceptive 
system can be upregulated in response 
to tissue injury.
Neuropathic pain
While nociceptive pain is the result of 
stimulation of the nervous system, neu-
ropathic pain is due to a lesion in the 
peripheral or central nervous system, 
e.g. in patients with diabetic or AIDS 
poly-neuropathy and post-herpetic 
neuralgia.
Dysfunctional pain
There is a large group of chronic pain 
patients where no peripheral abnormal-
ity or neurological deficit can be detect-
ed. The mechanism of pain is abnormal 
sensory processing of non-painful stimuli 
once the central nervous system has be-
come sensitized.11,14,17 These include the 
idiopathic pain disorders such as irritable 
bowel syndrome, chronic headaches, 
post-whiplash disorders, fibromyalgia 
syndrome and others.18
Both neuropathic and dysfunctional pain 
may be present in the absence of an 
ongoing peripheral stimulus or “organic 
cause”, and it is wrong to assume that 
these patients are only “psychological” 
or “hysterical”.11,17,18
Mixed pain
These include patients with cancer pain 
and low back pain (in particular low back 
pain following surgery, or failed back 
surgery syndrome) where neuropathic, 
nociceptive and myofascial compo-
nents may contribute to the patient’s 
pain experience.
Chronic pain
The IASP has defined chronic pain as 
“pain that persists for longer than the 
time expected for healing, or pain as-
sociated with progressive, non-malig-
nant disease”, usually taken to be three 
months.19
Chronic pain often persists long after 
the tissue trauma that has triggered its 
onset, has resolved and may be pres-
ent in the absence of identified ongoing 
tissue damage.20 Chronic pain is a dys-
functional response which mostly does 
not warn the individual of underlying 
disease or injury and has been widely 
acknowledged as a “disease in its own 
right”.21
Chronic pain may be associated with 
an underlying chronic disease such as 
arthritis. However, the largest group of 
chronic pain patients in the current epi-
demic in developed countries, comprises 
the chronic pain syndromes of unknown 
etiology.12 These pain syndromes have 
no confirmatory laboratory evidence 
and are diagnosed on the basis of 
clinical criteria, e.g. the headache syn-
dromes, irritable bowel syndrome, fibro-
myalgia and non-specific (or “simple”) 
low back pain.
The tendency to consider chronic 
pain as either psychological or phy-
sical, implies a false dichotomy – both 
play a role in most chronic pain disor-
ders, although the balance between 
organic pathology and psychosocial 
contributions may differ in different pain 
disorders. The emotional component 
of pain is complex and is influenced 
by past experiences, patient-beliefs 
and fears.22,23 Negative beliefs and an 
attitude of hopelessness may gene-
rate maladaptive illness behaviour with 
increased pain-reporting.22
Box 1: Management of chronic 
pain – biopsychosocial
1. Goals of management
2. Interdisciplinary approach
3. Effective communication
 • Emphasize patient’s active role
4. Pharmacological
•  Primary analgesics   
 Paracetamol
 NSAIDS / Coxibs
 Opioids
 • Secondary analgesics
  Antidepressants
  Anticonvulsants
  Local anaesthetics




8.  Occupational therapy (Return to 
work)
9. Interventional methods
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Pain assessment24,25,26,27
Pain is a subjective, complex and per-
sonal phenomenon and can only be as-
sessed indirectly by patient report.
Methods used for acute pain screening 
are insufficient to provide a compre-
hensive view of the multidimensional 
impact of chronic pain on the patient. In 
a patient with chronic pain, assessment 
should not be limited to pain severity, 
but at least also include pain-related 
functional interference and the emotional 
impact of the pain.
Uni-dimensional pain scales assess pain 
intensity and include numerical rating, 
visual analogue scales (VAS) and pic-
ture scales (facial expressions).
Multidimensional pain scales assess the 
effect of pain on mood, activities and 
quality of life, and include the McGill 
Pain Questionnaire and the Brief Pain 
Inventory.
A full clinical examination may provide 
clues to the causes of pain and formal 
psychological evaluation is indicated in 
a subset of chronic pain patients to as-
sess them for maladaptive pain behav-
iour, somatoform disorder, etc.
Management of chronic pain 
syndromes
The biomedical approach has tradition-
ally promised a cure by cutting or block-
ing the pain pathways pharmacologi-
cally or surgically. The biopsychosocial 
approach views pain as a dynamic inter-
action between physical, psychological 
and social factors, and more realistic 
treatment goals for patients include28:
•  The reduction, mostly not elimination, 
of pain
•  Improvement in physical / social 
functioning 
•  Improvement in mood and associ-
ated symptoms such as sleeping 
pattern
•  Development of active coping style 
and self-management-skills
• A return to work
•  Reduction in utilization of medical 
services
Evidence increasingly lends support 
to the use of an interdisciplinary ap-
proach where multiple therapies are 
provided in a co-ordinated manner, and 
where there is active interaction and a 
common philosophy that promotes ac-
tive patient involvement, between par-
ticipants.28,29
It is recommended that a core-team is 
involved in the primary care manage-
ment of chronic pain patients. Its com-
position will differ from area to area, also 
depending on the availability of resourc-
es and the complexity of a patient’s pain 
problem. A core-team may consist of 
a pain management physician (mostly 
a primary care doctor with a special 
interest in pain management) a phys-
iotherapist and occupational therapist. 
Additional members of an interdiscipli-
nary team in larger metropolitan areas 
may include, but are not limited to, an 
anaesthetist with interventional skills, a 
neurologist, an orthopaedic surgeon, a 
psychiatrist / psychologist, and a bioki-
netesist.
The roles of team members may also 
overlap and the physiotherapist may 
also be responsible for education, an 
exercise programme and to assist in 
applying the principles of cognitive be-
havioural therapy.28
It has been demonstrated that interdis-
ciplinary management, which empha-
sizes functional restoration produces 
the best outcomes in the management 
of chronic pain patients.30
Education
It is important to validate the patient’s 
pain complaint and to explain that factors 
that have initiated the pain problem are 
often different from those that maintain 
it. Fear-avoidance and catastrophyzing 
may intensify the pain-experience.
The patient should be informed about 
the goals of the treatment programme 
and certain chronic pain myths should 
be dispelled, including:31
•  Search long enough and you will find 
the cause and the cure
•  Abnormal scans validate and explain 
your pain
• Only organic pain is real
• You have to learn to live with it
•  Let pain be your guide – rest when it 
hurts
•  Hurt is equal to harm.
The outcome of pain management is 
often determined by what the doctor, 
therapist and patient expect.31
Physiotherapy, exercise and occupa-
tional therapy
The role of the physiotherapist is broad 
and includes education on pain mecha-
nisms and self-management, goal-set-
ting and a graded activity programme, 
pacing and helping patients to acquire 
problem-solving skills.32
An important element in physical re-
habilitation involves improvement in 
function through therapeutic exercises 
designed individually to increase func-
tional activity.
Passive manual methods are de-
emphasized in modern physiotherapy 
and should be integrated in a more 
active and comprehensive programme. 
Physiotherapists who are too somatically 
focussed, e.g. on the “degenerated disc” 
may reinforce illness behaviour and per-
petuate the problem.32
The physiotherapist should be informed 
on the cognitive and behavioural com-
ponents of pain presentation and assist 
in addressing inappropriate pain-be-
haviour. 
Occupational therapists work closely 
with physiotherapists in activity planning 
and in assessing domestic and work-
place circumstances.32 Return to work, 
even in the presence of some degree 
of pain, is an important component of 
chronic pain management.
Principles of pharmacological 
therapy33,34,35
•  The goal of pharmacotherapy should 
be to improve pain intensity and 
functioning while avoiding cognitive 
impairment and organ toxicity.
•  Many patients don’t present with pure 
nociceptive or neuropathic pain, but 
rather have a mixed pain syndrome, 
therefore rational polypharmacy is 
often appropriate.
•  The World Health Organization 
(WHO) analgesic three-step ladder 
for the rational use of analgesics in 
cancer pain, has also been applied 
for non-cancer pain for many years, 
in particular for nociceptive pain.
•  There is a move away from this 
empirical approach in chronic pain 
pharmacotherapy, to an approach 
that is targeted at the particular 
pain mechanism responsible for the 
patient’s pain (e.g. drugs that influ-
ence central sensitization).11
•  For continuous analgesia consider 
long-acting medication on a regular 
basis, rather than “as needed”.
•  Analgesics are generally more ef-
fective for nociceptive pain, and less 
effective for neuropathic pain.
Non-opioid analgesics
Paracetamol is still recommended as 
first-line therapy for osteo-arthritis.36
Non-steroidal anti-inflammatory drugs 
(NSAIDs) may be combined with 
paracetamol or opioids. Common side-
effects include GI irritation / peptic ul-
ceration and inhibition of platelet aggre-
gation. COX-2 specific agents (e.g. ce-
lecoxib and lumiracoxib) reduce these 
risks, but are also (similarly to older 
NSAIDs) associated with renal dysfunc-
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tion and potential cardiovascular side-




Codeine phosphate is a very weak an-
algesic and has almost no analgesic 
effect by itself. Its role in chronic pain 
management is very limited (if any).35
The long-term use of polycomponent co-
deine combinations (containing caffeine, 
meprobamate and others) is strongly 
discouraged in chronic pain. Their po-
tential for nephro-toxicity is greater and 
they are often associated with rebound 
pain.
Tramadol is an opioid of moderate 
strength and also inhibits nor-adrena-
line and serotonin re-uptake from nerve 
endings. A number of studies have 
demonstrated the efficacy of tramadol in 
chronic pain conditions such as neuro-
pathic pain, osteoarthritis, fibromyalgia 
and low back pain. It has a proven syn-
ergy with paracetamol, is not associated 
with peptic ulceration, renal dysfunction 
or cardiovascular side-effects and has a 
very low addictive potential.35,36
Strong opioids37,38,39
Current evidence supports the use of 
strong opioids in a carefully selected 
subset of patients with chronic and re-
sistant non-cancer pain.
A detailed assessment should be 
performed by an experienced pain 
management physician before strong 
opioids are prescribed. Strong opioid 
treatment for chronic pain should not be 
considered life-long treatment and only 
sustained – release opioids, e.g. trans-
dermal fentanyl and sustained release 
oral morphine, should be used.
Adjuvant drugs28,33,40
Neuropathic pain is mostly treated with 
medications that influence neurotrans-
mitters, e.g. antidepressants and anti-
epileptic drugs. Opioids are mostly 
reserved for patients with refractory 
neuropathic pain.
Antidepressants
•  Tricyclic antidepressants (e.g. amitrip-
tyline) are effective for neuropathic 
and non-neuropathic pain and its 
analgesic effect occurs at lower 
doses than its antidepressant effect. 
These drugs are associated with 
bothersome anti-cholinergic side-
effects and serious cardiovascular 
side-effects in older patients with 
established heart-disease.
•  Selective serotonin re-uptake in-
hibitors (SSRIs) are predominantly 
serotonergic drugs and are mostly 
ineffective in treating chronic pain.
•  Serotonin and norepinephrine re-
uptake inhibitors (SNRIs), e.g. dulox-
etine has proven efficacy in some 
patients with neuropathic pain and 
fibromyalgia (even in the absence of 
major depressive disorder).
Anti-epileptic drugs
Anti-epileptic drugs act at several sites 
that are relevant to pain perception and 
are believed to enhance central inhibi-
tion and limit neuronal excitation.
Of the first generation agents, carbam-
azepine is indicated for trigeminal neu-
ralgia. It has limited efficacy in patients 
with diabetic neuropathy and post-herpe-
tic neuralgia and is associated with 
many side-effects and toxicity.
Second generation antiepileptic drugs 
are better tolerated and have much 
fewer central nervous system side-
effects, e.g. gabapentin and pregabalin. 
Pregabalin inhibits discharges from 
injured nerves by inhibiting calcium-
channels pre-synaptically. It has a bet-
ter bio-availability than gabapentin and 
effectivity has been proven in several tri-
als in patients with diabetic neuropathy 
and post-herpetic neuralgia, as well as 
in fibromyalgia patients. (It is approved 
as such  by the US Food and Drug Ad-
ministration).11
Principles of behavioural 
therapy22,28,31,41,42
Several behavioural approaches may 
lead to long-term reduction in pain in-
tensity and improvement in physical and 
social functioning. In some chronic pain 
patients, the patient’s belief about the 
pain and its effects is a better predic-
tor of suffering and disability than the 
actual disease process and / or tissue 
damage.
Cognitive therapy aims to help patients 
identify maladaptive thinking patterns 
and develop the ability to challenge 
these thoughts.
Errors of thinking include:
• I will never get better
• There is nothing I can do
• I am afraid to move
•  The situation is hopeless because the 
pain is incurable
Engaging in pleasurable, stimulating 
and distracting activities are powerful 
means to limit disability.
Primary objectives in a programme of 
cognitive behavioural therapy include:
•  Change view of pain from overwhelm-
ing to manageable
•  Change from passive and helpless to 
active and competent
•  Be aware of the association between 
negative thoughts and maladaptive 
pain behaviour
• Teach specific coping skills
Interventions28,33,43
Less invasive methods
•  Myofascial trigger point therapy may 
provide pain relief and facilitate pa-
tient participation in active physical 
therapy, if it is correctly performed 
in selected patients with myofas-
cial pain syndrome,44,45 as part of a 
comprehensive pain management 
programme.
•  Nerve block therapy may be useful 
to allow patients to participate in ac-
tive rehabilitation. Sympathetic nerve 
blocks may be useful in some visceral 
pain states and in some patients 
with sympathetically maintained 
pains.28,43
•  Epidural steroid injections may pro-
vide temporary pain relief in patients 
with radicular low back pain.
•  Pulsed radiofrequency is a non-de-
structive procedure that may relieve 
chronic neuropathic pain in selected 
patients – however, more evidence is 
needed before official recommenda-
tion for this procedure in guidelines 
will be appropriate.45
More invasive methods
•  These include surgical procedures 
such as microvascular decompres-
sion for trigeminal neuralgia and 
joint-replacement surgery for severe 
osteoarthritis. Spinal surgery should 
be reserved for patients who are 
strictly selected by an interdisciplin-
ary team. Neurosurgical procedures 
include micro-DREZ-otomy for 
patients with intractable pain after 
plexus brachialis avulsion injuries.
•  Spinal cord stimulation has evolved 
as a reversible, non-destructive and 
low-morbidity technique for chronic 
intractable pain associated with isch-
aemia and certain refractory neuro-
pathic pain syndromes. It is however 
an expensive option.
•  Epidural and intrathecal drug delivery 
systems have been used success-
fully over many years in a carefully 
selected group of patients with in-
tractable pain when other therapies 
have failed.
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Summary
The last 20 years have seen an explo-
sion of both basic science and clinical 
research in the field of pain medicine. 
It is now clear that factors other than 
the injuring stimulus influence pain per-
ception and that untreated acute pain 
as well as many psycho-social factors 
may contribute to the neuroplasticity 
(“central sensitization”) that may occur 
in response to an initial pain stimulus 
and lead to chronic pain.
Once central sensitization has taken 
place, relatively innocuous stimuli may 
activate pain perception (hyperalgesia). 
This has lead to the recognition of pain 
as the “fi fth vital sign”, which should be 
monitored with the same vigilance as 
blood pressure, temperature, pulse and 
respiratory rate, e.g. in the management 
of patients after surgical or other forms 
of trauma.
Although John F Bonica brought recog-
nition to the multi-disciplinary approach 
to pain management, the publication 
in 1965 of the “gate control theory” by 
Melzack and Wall revolutionized the 
concept of pain and pain management. 
The recognition of chronic pain not only 
as a symptom, but as a disease itself, 
has been a major conceptual change. 
This has meant a shift in the manage-
ment of chronic pain to the multi-(inter-) 
disciplinary biopsychosocial approach 
where there is communication between 
team members and an emphasis on ac-
tive patient-participation and functional 
improvement.
This approach includes educational 
interventions as well as cognitive behav-
ioural approaches and supervised exer-
cise therapy. Appropriate pharmacologi-
cal treatment must be evidence-based 
and outcomes must include improve-
ment in the patient’s ability to function, 
not only pain-relief. Invasive therapy 
should be conservatively selected after 
comprehensive assessment and an 
appropriate period of comprehensive 
conservative management.  
See CPD Questionnaire, page 34
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